Posttreatment Lymphopenia Is Associated With an Increased Risk of Redeveloping Nontuberculous Mycobacterial Lung Disease in Patients With Mycobacterium avium Complex Lung Disease
K. Furuuchi (Kiyose, Tokyo, Japan), K. Fujiwara (Kiyose, Tokyo, Japan), F. Uesugi (Kiyose, Tokyo, Japan), M. Shimoda (Kiyose, Tokyo, Japan), Y. Tanaka (Kiyose, Tokyo, Japan), T. Yoshiyama (Kiyose, Tokyo, Japan), K. Yoshimori (Kiyose, Tokyo, Japan), A. Kurashima (Kiyose, Tokyo, Japan), K. Ohta (Kiyose, Tokyo, Japan), K. Morimoto (Kiyose, Tokyo, Japan)
Source: Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Furuuchi (Kiyose, Tokyo, Japan), K. Fujiwara (Kiyose, Tokyo, Japan), F. Uesugi (Kiyose, Tokyo, Japan), M. Shimoda (Kiyose, Tokyo, Japan), Y. Tanaka (Kiyose, Tokyo, Japan), T. Yoshiyama (Kiyose, Tokyo, Japan), K. Yoshimori (Kiyose, Tokyo, Japan), A. Kurashima (Kiyose, Tokyo, Japan), K. Ohta (Kiyose, Tokyo, Japan), K. Morimoto (Kiyose, Tokyo, Japan). Posttreatment Lymphopenia Is Associated With an Increased Risk of Redeveloping Nontuberculous Mycobacterial Lung Disease in Patients With Mycobacterium avium Complex Lung Disease. 3090
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: